LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$978
-58.4%
500.0%0.00%
Q2 2023$2,351
+12.1%
500.0%0.00%
Q1 2023$2,098
+10.0%
500.0%0.00%
Q4 2022$1,907
-4.6%
500.0%0.00%
Q3 2022$2,0000.0%500.0%0.00%
Q2 2022$2,0000.0%500.0%0.00%
Q1 2022$2,0000.0%500.0%0.00%
Q4 2021$2,0000.0%500.0%0.00%
Q3 2021$2,000
-33.3%
500.0%0.00%
Q2 2021$3,000
-25.0%
500.0%0.00%
Q4 2020$4,000
+33.3%
500.0%0.00%
Q3 2020$3,000
+50.0%
500.0%0.00%
Q2 2020$2,000
+100.0%
500.0%0.00%
Q1 2020$1,000
-75.0%
500.0%0.00%
Q4 2019$4,000
-42.9%
500.0%0.00%
Q3 2019$7,000
-22.2%
500.0%0.00%
Q2 2019$9,000
+12.5%
500.0%0.00%
Q1 2019$8,000
+60.0%
500.0%0.00%
Q4 2018$5,000
-28.6%
500.0%0.00%
Q3 2018$7,000
-12.5%
500.0%0.00%
Q2 2018$8,0000.0%500.0%0.00%
Q1 2018$8,0000.0%500.0%0.00%
Q4 2017$8,000
+166.7%
500.0%0.00%
Q3 2017$3,000
-25.0%
500.0%0.00%
Q2 2017$4,000500.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders